Fund management heavyweights at firms including Schroders, BNY Mellon Investment Management and Columbia Threadneedle have weighed in on what they see for 2021.

While some are warning that any stumbling blocks in how Covid vaccination programmes are rolled out globally are among investment risks in the year ahead, others are bullish on the prospects for environmental and social causes when it comes to investment.